Michael J. Kaplan
Academic Appointments
- Professor - Med Center Line, Otolaryngology (Head and Neck Surgery)
- Member, Stanford Cancer Institute
- Professor - Med Center Line (By courtesy), Neurosurgery
Key Documents
Contact Information
-
Clinical Offices
Otolaryngology - Head/Neck Surgery 875 Blake Wilbur Dr Clinic B Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 725-8502Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 725-5968 Tel (650) 498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Head and Neck Cancer
- Head and Neck Cancers
- Head and Neck Cancers - Head and Neck Surgery
- Skull Base Tumors
- Salivary Gland Tumors
- Esophageal Cancer
Administrative Appointments
- Head & Neck Oncology Program, Disease Management Leader, Stanford Cancer Center (2010 - present)
- Chief, Head & Neck Surgery, Otolaryngology-Head&Neck Surgery (2003 - present)
- Head & Neck Fellowship Director, Otolaryngology-Head&Neck Surgery (2003 - present)
Honors and Awards
- Best Doctors in America, . (1998-2012)
- Chief Residents' Special Certificate of Merit, UCSF (1993)
- Roger Boles Teaching award, UCSF (1987)
- Phi Beta Kappa, Harvard College (1973)
Professional Education
| Internship: | Beth Israel Deaconess Medical Center MA (1978) |
| Fellowship: | University of Virginia VA (1984) |
| Board Certification: | Otolaryngology, American Board of Otolaryngology (1982) |
| Residency: | Massachusetts Eye and Ear Infirmary MA (1982) |
| Residency: | Beth Israel and Children's Hospital MA (1979) |
| Medical Education: | Harvard Medical School MA (1977) |
Graduate & Fellowship Program Affiliations
Community and International Work
- Scientific Review Committee, Stanford Cancer Center, International&suffix=
- Institutional Review Board, Stanford, Stanford&suffix=
- Ethic Committee, US&suffix=
- American Youth Soccer Organization referree, Bay Area&suffix=
- Mill Valley Schools Configuration Task Forc, Mill Valley&suffix=
Scientific Focus
Current Research Interests
1) New therapeutic approaches for head and neck cancer, including immune stimulation possibilities (IRX-2 protocol), integration of biological modifiers, and, eventually, genetic approaches.
2) Head and neck cancer stem cells: identification, characterization, control--in conjunction with the Irv Weissman and Michael Clarke labs in the Stem Cell Institute
3) Development of innovative surgical methods at the anterior cranial base
Clinical Trials
- Recruiting Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
- Recruiting Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
- Not Recruiting Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Not Recruiting Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
- Not Recruiting Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
Publications
- Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013; (7): 1349-56
- Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas. Laryngoscope. 2013
- Radiotherapy for nonadenoid cystic carcinomas of major salivary glands. Am J Otolaryngol. 2013
- Stereotactic radiosurgery for retreatment of gross perineural invasion in recurrent cutaneous squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2013; (3): 293-8
- Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2012 Mar-Apr; (2): 166-73
- CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2012; (6): 465-70
Help
Trial Administration